Stay updated on Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in HAE Clinical Trial page.

Latest updates to the Lanadelumab in HAE Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history shows a software version update from v3.5.0 to v3.5.2, with no changes to study records or content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the Record History page.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded revision entry v3.4.3 and removed revision entry v3.4.2 from the study record history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new Revision: v3.4.2 is added, and the prior notices about government funding status and the Revision: v3.4.1 are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check86 days agoChange DetectedA site-wide banner about government funding lapse and current operating status was added, with links to cc.nih.gov and opm.gov. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check93 days agoChange DetectedUI updates include a new 'Show glossary' option and explanatory text about color-coding of changes. The page also shows updated revision/version information.SummaryDifference1%

Stay in the know with updates to Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in HAE Clinical Trial page.